SGAustria

SGAustria is a biotechnology company based in Austria that focuses on the development of innovative peptide-based therapeutics targeting metabolic and gastrointestinal disorders. The company leverages its expertise in G protein-coupled receptor (GPCR) signaling to design highly specific agonists and antagonists for receptors such as the secretin and glucagon-like peptide receptors. Their primary research efforts are directed toward addressing unmet medical needs in conditions like short bowel syndrome and metabolic syndrome. SGAustria operates as a lean, research-driven entity, often collaborating with academic institutions to advance its early-stage pipeline. The company's lead programs are currently in the pre-clinical phase, aiming to optimize drug delivery and efficacy profiles.